by Lance Smith | Mar 18, 2020 | Study Scavenger Clinical Trial Recruitment Platform
CAMBRIDGE, Mass., March 17, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that it has initiated a Phase 1/1b...by Lance Smith | Mar 18, 2020 | Study Scavenger Clinical Trial Recruitment Platform
− Rapid development of research program on investigational Prostate Specific Membrane Antigen-targeted radiohybrid PET imaging agent since company’s 2018 acquisition − BURLINGTON, Mass. & OXFORD, England–(BUSINESS WIRE)–Blue Earth Diagnostics, a Bracco...by Lance Smith | Mar 18, 2020 | Study Scavenger Clinical Trial Recruitment Platform
Applied Genetic Technologies Corporation has completed enrollment in all dose groups for adult patients with achromatopsia in its phase 1/2 clinical programs, according to a press release. The company is evaluating the safety and efficacy of rAAV2tYF-PR1.7-hCNGA3 in...by Lance Smith | Mar 18, 2020 | Study Scavenger Clinical Trial Recruitment Platform
A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The National Institute of Allergy and Infectious...by Lance Smith | Mar 18, 2020 | Study Scavenger Clinical Trial Recruitment Platform
VANCOUVER, Washington, March 16, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic...